drugset / Trial / NCT00005590

Levofloxacin to Prevent Infection Following Chemotherapy in Treating Patients With Solid Tumors or Lymphoma

NCT00005590

RandomizedDouble-blindSupportive care

Summary

RATIONALE: Giving antibiotics may be effective in preventing or controlling early infection in patients receiving chemotherapy for solid tumors or lymphoma. It is not yet known if levofloxacin if effective in preventing infection. PURPOSE: Randomized phase III trial to determine the effectiveness of levofloxacin in preventing infection in patients receiving chemotherapy for solid tumors or lymphoma.

Timeline

Start
1999-08
Primary completion
Completion
2005-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Levofloxacin Small molecule 500 mg Oral